A retrospective cohort study of the Impact of Urokinase supply deficiency on acute Empyema practice Outcome(AIUEO study)

A retrospective cohort study of the Impact of Urokinase supply deficiency on acute Empyema practice Outcome(AIUEO study) - The impact of urokinase supply deficiency on empyema practice outcome(AIUEO study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055429

Enrollment

100

Registered

2024-09-29

Start date

2024-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

empyema

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients 18 years of age or older who were diagnosed with acute empyema and started treatment including thoracic drainage at our department during the eligible period.

Exclusion criteria

Exclusion criteria: 1) Patients who did not undergo thoracic drainage 2) Patients with chronic empyema 3) Patients with tuberculous pleurisy 4) Patients who have indicated their refusal to participate in this study either by themselves or by their family members.

Design outcomes

Primary

Measure	Time frame
Transfer to sugery	—

Secondary

Measure	Time frame
In-hospital mortality rate Days from start of thoracic drainage to referral for respiratorysurgery Duration of hospital stay Duration of antimicrobial therapy Duration of chest drain placement Home discharge rate Treatment-related adverseevents	—

Countries

Japan

Contacts

Public ContactRyunosuke Inaba

Seirei Mikatahara General Hospital Department of respiratory medicine, Respiratory disease center

i78rrr@gmail.com053-436-1251

Outcome results